AnaptysBio Inc - Company Profile

Powered by

All the data and insights you need on AnaptysBio Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date AnaptysBio Inc Strategy Report

  • Understand AnaptysBio Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

AnaptysBio Inc: Overview

Select Item

AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody candidates for the treatment of atopic dermatitis, ovarian cancer, lung cancer, asthma, psoriasis, inflammation and other autoimmune indications. The company develops its product candidates through its proprietary antibody discovery technology platform that is based on somatic hypermutation (SHM). The company has various product candidates under development for the treatment of moderate-to-severe adult atopic dermatitis, asthma, generalized pustular psoriasis and palmo-plantar pustular psoriasis, and human autoimmune diseases. The company has partnership with GlaxoSmithKline and Bristol-Myers Squibb to develop its product candidates. AnaptysBio is headquartered in San Diego, California, the US.

 Gain a 360-degree view of AnaptysBio Inc and make more informed decisions for your business Gain a 360-degree view of AnaptysBio Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 10770 Wateridge Circle, Suite 210, San Diego, California, 92121
Website www.anaptysbio.com
Telephone 1 858 3626295
No of Employees 117
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange ANAB (NASD)
Revenue (2022) $17.2M 66.8% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -27.1% (2022 vs 2021)
Market Cap* $607.8M
Net Profit Margin (2022) XYZ 23.8% (2022 vs 2021)
* As of and is in US$
View AnaptysBio Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

AnaptysBio Inc premium industry data and analytics

70+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for AnaptysBio Inc’s relevant decision makers and contact details.

50+

Catalyst Calendar

Proactively evaluate AnaptysBio Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

30+

Clinical Trials

Determine AnaptysBio Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of AnaptysBio Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

12+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

3

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on AnaptysBio Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Pipeline
Rosnilimab: Inflammatory Diseases
Imsidolimab:
XYZ
XYZ
XYZ
Understand AnaptysBio Inc portfolio and identify potential areas for collaboration Understand AnaptysBio Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters AnaptysBio Inc F. Hoffmann-La Roche Ltd AbbVie Inc Sanofi Novartis AG
Headquarters United States of America Switzerland United States of America France Switzerland
City San Diego Basel North Chicago Paris Basel
State/Province California - Illinois Ile-de-France -
No. of Employees 117 103,605 50,000 87,994 76,057
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
John Orwin Chairman Executive Board 2024 -
Daniel Faga Chief Executive Officer; Director; President - Interim Executive Board 2022 43
Dennis Mulroy Chief Financial Officer Senior Management 2020 68
Eric Loumeau Chief Legal Officer Senior Management - 60
Paul F. Lizzul, M.D., Ph.D Chief Medical Officer Senior Management 2020 48
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into AnaptysBio Inc key executives to enhance your sales strategy Gain insight into AnaptysBio Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward